Acadian Asset Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,563
| Closed | -$63K | – | 1829 |
|
|
2023
Q3 | $63K | Sell |
4,563
-2,624
| -37% | -$36.2K | ﹤0.01% | 1398 |
|
|
2023
Q2 | $74K | Buy |
7,187
+2,624
| +58% | +$27K | ﹤0.01% | 1464 |
|
|
2023
Q1 | $42K | Buy |
+4,563
| New | +$42K | ﹤0.01% | 1542 |
|
|
2018
Q2 | – | Sell |
-5,315
| Closed | -$264K | – | 1849 |
|
|
2018
Q1 | $264K | Sell |
5,315
-18,425
| -78% | -$915K | ﹤0.01% | 1000 |
|
|
2017
Q4 | $884K | Sell |
23,740
-853
| -3% | -$31.8K | ﹤0.01% | 712 |
|
|
2017
Q3 | $775K | Buy |
+24,593
| New | +$775K | ﹤0.01% | 724 |
|